Triple therapy of RAS inhibitors, dapagliflozin, and finerenone in diabetic kidney disease patients with nephrotic-range proteinuria: a real-world study

C Chenjie Gu X Xinwei Li (Shenyang National Laboratory for Materials Science, Institute of Metal Research, Chinese Academy of Sciences, 72 Wenhua Road, Shenyang 110016, P. R. China) X Xianan Guo J Jingying Zhou (Future Battery Research Center, Global Institute of Future Technology) L Le Kang M Ming Fang

Article Details

Volume / Issue Vol. 15, Issue 1
Published December 08, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (6)

C

Chenjie Gu

X

Xinwei Li

Shenyang National Laboratory for Materials Science, Institute of Metal Research, Chinese Academy of Sciences, 72 Wenhua Road, Shenyang 110016, P. R. China

X

Xianan Guo

J

Jingying Zhou

Future Battery Research Center, Global Institute of Future Technology

L

Le Kang

M

Ming Fang